(Q37235641)

19 August 2017

1 reference

title

Clozapine-induced agranulocytosis and its genetic determinants (English)

1 reference

19 August 2017

1 reference

Carolin Opgen-Rhein

1

1 reference

19 August 2017

Michael Dettling

series ordinal

2

1 reference

19 August 2017

language of work or name

1 reference

1 August 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

9

1 reference

19 August 2017

issue

8

1 reference

19 August 2017

page(s)

1101-1111

1 reference

Population-based drug-induced agranulocytosis

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Systematic review: agranulocytosis induced by nonchemotherapy drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Blood dyscrasias induced by psychotropic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Neutropenia and anaemia due to carbimazole-dependent antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Atypical antipsychotic-induced neutropenia in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

21 January 2018

The history of clozapine

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Agranulocytosis during treatment with chlozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Genetic susceptibility to adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Idiosyncratic drug reactions: a mechanistic evaluation of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Schizophrenia and HLA: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Analysis of the distribution of HLA-B alleles in populations from five continents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Mitchell B. Balter Award. Human leukocyte antigen-A1 predicts a good therapeutic response to clozapine with a low risk of agranulocytosis in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Stress-induced release of HSC70 from human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Investigation of linkage and association/linkage disequilibrium of HLA A-, DQA1-, DQB1-, and DRB1-alleles in 69 sib-pair- and 89 trio-families with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

No association between the tumor necrosis factor-alpha gene promoter polymorphisms and schizophrenia in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Effects of clozapine on plasma cytokine and soluble cytokine receptor levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Association of NRH:quinone oxidoreductase 2 gene promoter polymorphism with higher gene expression and increased susceptibility to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Catalog of 320 single nucleotide polymorphisms (SNPs) in 20 quinone oxidoreductase and sulfotransferase genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

A possible association between an insertion/deletion polymorphism of the NQO2 gene and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Functional polymorphism of the NQO2 gene is associated with methamphetamine psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

NQO2 gene is associated with clozapine-induced agranulocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

IgG receptor polymorphisms: risk factors for disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Fcgamma receptors as regulators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

NQO1, MPO, and the risk of lung cancer: a HuGE review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Myeloperoxidase: new polymorphisms and relation with lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

A myeloperoxidase polymorphism associated with reduced risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Mechanism for phosphorylation-induced activation of the phagocyte NADPH oxidase protein p47(phox). Triple replacement of serines 303, 304, and 328 with aspartates disrupts the SH3 domain-mediated intramolecular interaction in p47(phox), thereby acti

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Continuing clozapine treatment despite neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Late onset neutropenia during clozapine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Rechallenge with clozapine following leucopenia or neutropenia during previous therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

Association between −G308A tumor necrosis factor alpha gene polymorphism and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1101

10.2217/14622416.9.8.1101

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference